4/A//SEC Filing
Sniecinski Megan 4/A
Accession 0001127602-19-035852
CIK 0000882796other
Filed
Dec 25, 7:00 PM ET
Accepted
Dec 26, 5:13 PM ET
Size
5.2 KB
Accession
0001127602-19-035852
Insider Transaction Report
Form 4/AAmended
Sniecinski Megan
Chief Business Officer
Transactions
- Award
Emp. Stock Option (Right to Buy)
2019-12-17+240,000→ 240,000 totalExercise: $3.23From: 2020-12-17Exp: 2029-12-17→ Common Stock (240,000 underlying)
Footnotes (1)
- [F1]Annual Employee Option Grant becomes exercisable at the rate of 25% on each of the first, second, third and fourth anniversaries of the date of grant.
Documents
Issuer
BIOCRYST PHARMACEUTICALS INC
CIK 0000882796
Entity typeother
Related Parties
1- filerCIK 0001781480
Filing Metadata
- Form type
- 4/A
- Filed
- Dec 25, 7:00 PM ET
- Accepted
- Dec 26, 5:13 PM ET
- Size
- 5.2 KB